11 completed. 11 Phase 3, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 11 | Completed 11 |
| Phase 2 | 4 | Completed 4 |
Follow Allergic Rhinoconjunctivitis: new trials by email Literature Review of Allergic Rhinoconjunctivitis trials Research Report on Allergic Rhinoconjunctivitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Research Study of House Dust Mite (HDM) SLIT-tablet for the Treatment of HDM Allergy in Chinese Participants Aged 12-65 HDM SLIT-tablet (12 SQ-HDM), Placebo - Allergic Rhinoconjunctivitis, Allergic Rhinitis | Phase 3 | Completed | ALK-Abelló A/S | 327 | 2025-09-01 | 2026-10-05 |
| Safety and Efficacy of STALORAL® Birch 300 IR in a Paediatric Population With Birch Pollen-induced ARC w/o Asthma STALORAL® Birch 300 IR - Allergic Rhinoconjunctivitis, Birch Pollen Allergy | Phase 3 | Completed | Stallergenes Greer | 553 | 2023-09-20 | 2025-11-26 |
| Adolescent Mite Allergy Safety Evaluation HDM SLIT-tablet - Allergic Rhinitis, Allergic Rhinoconjunctivitis | Phase 3 | Completed | ALK-Abelló A/S | 253 | 2020-09-23 | 2023-07-03 |
| Efficacy and Safety of Intraseasonal Specific Immunotherapy With Depiquick® Birch Depiquick Birch (DPG103), Placebo - Allergic Rhinoconjunctivitis | Phase 3 | Completed | Novartis | 202 | 2012-03-01 | 2017-03-22 |
| Avanz Phleum Pratense Maintenance Dose Avanz Phleum pratense, Placebo - Allergic Rhinoconjunctivitis | Phase 2 / Phase 3 | Completed | ALK-Abelló A/S | 450 | 2011-09-01 | 2014-01-22 |
| An Open Trial to Assess the Tolerability of AVANZ Phleum Pratense Immunotherapy AVANZ Phleum pratense - Allergic Rhinoconjunctivitis | Phase 2 / Phase 3 | Completed | ALK-Abelló A/S | 199 | 2011-06-01 | 2015-03-06 |
| A Trial Evaluating Tolerability of Grazax Treatment in Combination With Antihistamine Grazax + Aerius, Grazax + placebo - Allergic Rhinoconjunctivitis | Phase 3 | Completed | ALK-Abelló A/S | 46 | 2008-09-01 | 2013-02-08 |
| Multicenter Trial of Sublingual Immunotherapy With a Solution of Grass Pollen Allergen Extract in Children Grass pollen allergens in a water/glycerol solution, Placebo - Allergic Rhinoconjunctivitis | Phase 3 | Completed | Allergopharma GmbH & Co. KG | 207 | 2008-02-01 | 2015-10-16 |
| Subcutaneous Immunotherapy Treatment for Patients With Hypersensitivity to Parietaria Judaica Depigoid Parietaria judaica 1000DPP/ml, Placebo - Allergic Rhinoconjunctivitis | Phase 3 | Completed | Laboratorios Leti, S.L. | 153 | 2008-02-01 | 2013-11-11 |
| Long-term Efficacy and Safety Study With Oralgen Grass Pollen Oralgen, placebo - Allergic Rhinoconjunctivitis | Phase 2 / Phase 3 | Completed | Artu Biologicals | 356 | 2007-08-01 | 2010-05-05 |
| Efficacy and Safety of Grass Pollen Sublingual Immunotherapy Oralgen, grass pollen extract - Allergic Rhinoconjunctivitis | Phase 2 / Phase 3 | Completed | Artu Biologicals | 605 | 2006-12-01 | 2010-05-05 |
Hypersensitivity (2) · Rhinitis, Allergic (2)
Immune System Diseases (4) · Hypersensitivity (2) · Hypersensitivity, Immediate (2) · Nose Diseases (2) · Otorhinolaryngologic Diseases (2) · Respiratory Hypersensitivity (2) · Respiratory Tract Diseases (2) · Rhinitis (2)
Grazax (1) · desloratadine (1) · grass pollen extract, alum-adsorbed (1)
ALK-Abelló A/S (5) · Artu Biologicals (2) · Allergopharma GmbH & Co. KG (1) · Laboratorios Leti, S.L. (1) · Novartis (1) · Stallergenes Greer (1)
Germany (8) · Slovakia (4) · Bulgaria (3) · Czechia (3) · Hungary (3) · Lithuania (3) · Netherlands (2) · Spain (2) · Austria (1) · China (1) · Finland (1) · France (1) · Latvia (1) · Poland (1) · Romania (1)
Andreas Horn, MD (1) · Angel Ferrer, Dr (1) · Dyonne van Duren, MD, PhD (1) · Folkert R Roossien (1) · Iveta Kozlovska, MD, PhD (1) · Knut Schaekel, MD, PhD (1) · Oliver Pfarr, MD (1) · Ulrich Wahn, MD (1)
2025 (1)